CVS Caremark’s SilverScript inks collaborations with ACOs
WOONSOCKET, R.I. — SilverScript Insurance Co., a CVS Caremark company, has entered into collaborations with seven accountable care organizations across the country.
The collaborations are designed to help improve pharmacy care for Medicare Part D beneficiaries who are served by the participating ACO and also enrolled in a SilverScript Medicare Part D Prescription Drug Plan, the company stated.
The collaborating ACOs include Monarch Healthcare ACO and National ACO in California; American Health Alliance, Orange Accountable Care, Orange Accountable Care of South Florida, and West Florida ACO in Florida; and VirtualCare ACO in New Jersey.
"Our expertise and access to patient prescription data can help these Accountable Care Organizations identify those Medicare Part D patients who could benefit from interventions designed to improve medication adherence, reduce gaps in care and help reduce overall pharmacy spend," stated Troyen A. Brennan, chief medical officer, CVS Caremark. "We believe this partnership can help our ACO partners improve key quality measures for their Medicare patients and improve health outcomes in line with our purpose of helping people on their path to better health."
Through the collaboration, clinicians at the participating ACOs will be able to track prescription activity and usage for the SilverScript beneficiaries they treat, including the use of generic versus brand prescriptions and the identification of any medication adherence issues or gaps in care. Based on this information, they will work to develop and implement appropriate interventions.
As a Medicare Part D PDP sponsor, SilverScript implements a medication therapy management program that includes medication reviews and other adherence and gaps in care programs that enhance the coordination of pharmacy care for beneficiaries. Through these programs, SilverScript beneficiaries are counseled individually about maintenance medications, patient concerns and any potential risks. These programs are designed to identify concerns around adherence to maintenance medications and possible risks, such as drug-to-drug interactions, duplicate therapies or high-risk medications.
These seven Accountable Care Organizations join an existing group of ACOs across the country that SilverScript has been working in collaboration with to improve pharmacy care for the Medicare Part D beneficiaries they serve. These ACOs include PriMed in Connecticut, Franciscan Alliance ACO in Indiana, Jordan Community ACO in Massachusetts, Dartmouth-Hitchcock Health in New Hampshire, and Atlantic ACO in New Jersey.
Dollar General CEO retiring
GOODLETTSVILLE, Tenn. — Dollar General on Friday announced that its chairman and CEO, Rick Dreiling has informed the board of directors of his intent to retire as CEO effective May 30, 2015 or upon the appointment of a successor. Dreiling has agreed to serve, at the discretion of the board, as chairman during a transition period following the appointment of a new CEO.
Dreiling has served as CEO since January 2008 and was named chairman of the board in December 2008. Under his leadership, the company's annual sales have increased more than 80% to $17.5 billion in 2013 and store count has increased by 38% to more than 11,000 stores in 40 states.
"Dollar General is a great company because of our people and our mission of serving others. I am extremely proud of Dollar General's track record of success over the past six years, and I am honored to have had the opportunity to lead such an experienced and talented team," Dreiling stated. "Dollar General is in a strong position today, and I'm confident it has excellent prospects for the future. After considerable reflection, I am at a point where it is appropriate to begin to plan for my retirement. I plan to work with the board of directors on recruiting and mentoring a new CEO."
Mike Calbert, the company's lead director, said, "Rick Dreiling has proven that he is clearly one of retail's leading CEOs. On behalf of the entire board of directors, I want to thank Rick for his outstanding leadership. During his tenure as CEO, Rick has driven significant shareholder value and led the company's improvement on essentially every key operating metric. In addition, he has recruited and developed an outstanding management team and strengthened the company's culture and mission. The board is confident the company is well-positioned as we search for a new CEO. We're fortunate to have Rick in his role until the new CEO assumes these duties."
The Dollar General board of directors is conducting an internal and external search for a CEO.
ABC acquires minority stake in Brazil’s Profarma Distribuidora de Produtos Farmacêuticos
VALLEY FORGE, Pa. — AmerisourceBergen on Thursday announced that it has completed the acquisition of a minority stake in Profarma Distribuidora de Produtos Farmacêuticos, a leading pharmaceutical wholesaler in Brazil. In addition, AmerisourceBergen and Profarma have launched a joint venture to provide enhanced specialty distribution and services to the Brazilian marketplace.
The company has invested a total of approximately $110 million in an approximately 19.9% minority stake in Profarma, and a 50% stake in the specialty joint venture.
“With Profarma’s long history of success and AmerisourceBergen’s extensive expertise in specialty distribution, I am very excited about the potential this unique combination brings to the Brazilian market,” stated Steven Collis, AmerisourceBergen president and CEO. “This represents a tremendous opportunity to expand our international presence, introduce new products and services into a fast-growing market, and enhance future growth for both companies.”
Profarma believes that it has taken two important steps with the capital increase and the creation of the joint venture. “We feel proud of and motivated by the association with AmerisourceBergen. We believe both companies will benefit from sharing knowledge and experience. In addition, the capital increase gives us the strength we need to forge ahead with our growth strategy,” commented Sammy Birmacker, Profarma’s CEO.
The specialty joint venture will be led by Craig Miller, who will serve as the CEO of the specialty joint venture, and who previously led AmerisourceBergen’s U.S. BioServices. “I am looking forward to helping shape healthcare delivery in Brazil through our knowledge, reach and partnership with Profarma, and to the benefit of our manufacturer and healthcare provider customers worldwide,” said Miller.